# Early Detection of Cardiac Damage With CMR in Women With Breast Cancer

> **NCT04046315** · — · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 55 (estimated)

## Conditions studied

- Cardiotoxicity
- Breast Cancer
- Chemotherapy Induced Systolic Dysfunction

## Interventions

- **DIAGNOSTIC_TEST:** CMR

## Key facts

- **NCT ID:** NCT04046315
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2020-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04046315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04046315, "Early Detection of Cardiac Damage With CMR in Women With Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04046315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*